The Evolut Low Risk Trial: Self-expanding TAVR noninferior to surgery in...

1. Among patients with severe aortic stenosis at low-risk for surgery, transcatheter aortic valve replacement (TAVR) with a self-expanding valve was noninferior to surgical...

The PARTNER 3 Trial: TAVR with balloon-expandable valves has favorable post-surgical...

1. This randomized control trial compared post-surgical outcomes between transcatheter aortic-valve replacement (TAVR) with balloon-expandable valves or surgical valve replacement in low- risk surgical...
licensing as small

All-time hits